APOH | Apolipoprotein H (beta-2-glycoprotein I) | Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ARFIP2 | ADP-ribosylation factor interacting protein 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ARHGAP36 | Rho GTPase activating protein 36 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ARHGAP6 | Rho GTPase activating protein 6 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
ARNTL | Aryl hydrocarbon receptor nuclear translocator-like | Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
ARSA | Arylsulfatase A | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ARSB | Arylsulfatase B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ARSG | Arylsulfatase G | Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ASAH2 | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
ASCL1 | Achaete-scute family bHLH transcription factor 1 | Predicted secreted proteins Transcription factors
| | | | | Tissue enriched |
ATG5 | Autophagy related 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP5F1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AUH | AU RNA binding protein/enoyl-CoA hydratase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
AXIN2 | Axin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
AZU1 | Azurocidin 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT1 | Beta-1,4-N-acetyl-galactosaminyl transferase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
BCAP29 | B-cell receptor-associated protein 29 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
BGN | Biglycan | Predicted secreted proteins
| | | | | Mixed |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
BPI | Bactericidal/permeability-increasing protein | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BPIFA2 | BPI fold containing family A, member 2 | Predicted secreted proteins
| | | | | Tissue enriched |
BPIFA3 | BPI fold containing family A, member 3 | Predicted secreted proteins
| | | | | Tissue enriched |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BPIFB2 | BPI fold containing family B, member 2 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
BSG | Basigin (Ok blood group) | Blood group antigen proteins CD markers Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | | | | Group enriched |
C16orf89 | Chromosome 16 open reading frame 89 | Predicted secreted proteins
| | | | | Group enriched |
C19orf10 | Chromosome 19 open reading frame 10 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C1GALT1 | Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf56 | Chromosome 1 open reading frame 56 | Predicted secreted proteins
| | | | | Tissue enriched |
C1QA | Complement component 1, q subcomponent, A chain | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
C1S | Complement component 1, s subcomponent | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C21orf33 | Chromosome 21 open reading frame 33 | Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C2CD2 | C2 calcium-dependent domain containing 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C3 | Complement component 3 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Group enriched |
C6orf58 | Chromosome 6 open reading frame 58 | Predicted secreted proteins
| | | | | Group enriched |